Addition of a disclaimer to a claim, based on words not present in the application as filed, is referred to as an undisclosed disclaimer.
Judy M. Mohr, PhD
Advertisement
Perkins Coie, LLP
Articles by Judy M. Mohr, PhD
The courts regard biotechnology as highly unpredictable
Only the product that served as the basis of the extension is exclusively covered by the patent during its extended term.
Advertisement
Latest Updated Articles
- IP Briefs: The Positive Side of Negative Disclaimers
June 1st 2007
Advertisement
Advertisement
Trending on BioPharm International
1
Regeneron's Libtayo Earns CHMP Nod for Expanded EU Dosing
2
Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
3
The BioPharm Brief: New Approval, Pediatric Progress, and Durable Remission
4
Biomarker Testing Gaps Can Stall Targeted Oncology Therapy, BMS’s Dr Pennell Says
5